Recent Advancements in Topical Anti-Psoriatic Nanostructured Lipid Carrier-Based Drug Delivery

Area of Science:

• Dermatology
• Nanotechnology
• Pharmaceutics

Background:

• Psoriasis involves abnormal keratinocyte proliferation and differentiation, impacting patient quality of life.
• Current psoriasis treatments offer symptomatic relief but have adverse effects.
• Nanostructured lipid carriers (NLCs) are advanced nanocarriers with improved properties.

Purpose of the Study:

• To review the potential of NLCs for psoriasis treatment.
• To discuss the advantages, mechanism, and formulations of NLCs in psoriasis therapy.
• To examine patents and regulatory aspects of NLCs for psoriasis.

Main Methods:

• Literature review of psoriasis pathophysiology and current treatments.
• Analysis of NLC properties and their application in drug delivery for skin conditions.
• Compilation of relevant patents and regulatory considerations for nanoformulations.

Main Results:

• NLCs demonstrate sustained drug release, enhanced skin hydration, penetration, retention, and bioavailability.
• NLCs can encapsulate both hydrophobic and hydrophilic drugs.
• NLCs show reduced staining and fewer side effects compared to conventional ointments.

Conclusions:

• NLC nanoformulations show significant promise for effective psoriasis treatment.
• Academic-industry collaboration and robust regulatory frameworks are essential for NLC commercialization.
• NLCs represent a next-generation nanocarrier system for dermatological applications.